webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-N-amido-PEG9-acid

  CAS No.: 1191064-81-9   Cat No.: BADC-00895   Purity: ≥95% 4.5  

Fmoc-N-amido-PEG9-acid is a high-performance ADC linker featuring a PEG9 spacer that enhances solubility and flexibility. It facilitates efficient and stable drug-antibody conjugation, making it ideal for targeted cancer therapy development.

Fmoc-N-amido-PEG9-acid

Structure of 1191064-81-9

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C36H53NO13
Molecular Weight
707.80
Shipping
Room temperature
Storage
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Fmoc-NH-PEG9-CH2CH2COOH; 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31-decaoxa-4-azatetratriacontan-34-oic acid; Fmoc-NH-PEG9-acid; Fmoc-PEG9-propionic acid; 1-(Fmoc-amino)-3,6,9,12,15,18,21,24,27-nonaoxa-30-triacontanoic Acid; 5,8,11,14,17,20,23,26,29-Nonaoxa-2-azadotriacontanedioic acid 1-(9H-fluoren-9-ylmethyl) ester; 2,7,10,13,16,19,22,25,28,31-Decaoxa-4-azatetratriacontan-34-oic acid, 1-(9H-fluoren-9-yl)-3-oxo-
IUPAC Name
3-[2-[2-[2-[2-[2-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O
InChI
InChI=1S/C36H53NO13/c38-35(39)9-11-41-13-15-43-17-19-45-21-23-47-25-27-49-28-26-48-24-22-46-20-18-44-16-14-42-12-10-37-36(40)50-29-34-32-7-3-1-5-30(32)31-6-2-4-8-33(31)34/h1-8,34H,9-29H2,(H,37,40)(H,38,39)
InChIKey
NEESTRVILHNOJT-UHFFFAOYSA-N
Density
1.186±0.06 g/cm3 at 20°C, 760 Torr
Solubility
Soluble in DCM, DMF, DMSO
Flash Point
440.0±34.3 °C
Index Of Refraction
1.526
Vapor Pressure
0.0±3.0 mmHg at 25°C
Appearance
Pale Yellow or Colorless Oily Liquid
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at 2-8°C
Boiling Point
803.9±65.0 °C at 760 mmHg

Fmoc-N-amido-PEG9-acid, a versatile compound widely applied in peptide synthesis and biomedical research, presents a spectrum of pivotal functions.

Peptide Synthesis: Serving as a fundamental component in solid-phase peptide synthesis, Fmoc-N-amido-PEG9-acid plays a crucial role in constructing peptides. Acting as a spacer, it enhances the solubility and flexibility of resulting peptides, particularly those of intricate nature, utilized in therapeutic and diagnostic realms. The compound enables the efficient and dependable synthesis of complex peptides.

Drug Delivery: Embracing innovation in drug delivery systems, Fmoc-N-amido-PEG9-acid is instrumental in designing novel approaches. The incorporation of the PEG moiety elevates the solubility and stability of drug molecules, bolstering their bioavailability and circulation time within the body. This characteristic is particularly advantageous for formulating peptide and protein drugs that necessitate prolonged systemic exposure.

Surface Modification: Extending its reach to surface functionalization, Fmoc-N-amido-PEG9-acid is harnessed for modifying diverse surfaces, including nanoparticles, biomaterials, and medical devices. By tethering PEG chains to these surfaces, the compound mitigates protein adsorption and cell adhesion, thereby amplifying biocompatibility. This technique of surface modification is vital for crafting therapeutics and implants that minimize immune reactions, leading to enhanced patient outcomes and improved clinical efficacy.

Bioconjugation: Playing a pivotal role in bioconjugation strategies, Fmoc-N-amido-PEG9-acid facilitates the linkage of biomolecules like antibodies, enzymes, and nucleic acids to synthetic carriers or other biomolecules. The PEG linker ensures that the conjugated molecules retain their biological activity and functionality, thereby enabling the development of targeted therapies, diagnostic assays, and biosensors.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Mal-PEG2-Val-Cit-amido-PAB-OH | Amino-Tri-(carboxyethoxymethyl)-methane | Azido-PEG6-NHS ester | PC Alkyne-PEG4-NHS ester | Azido-PEG3-Val-Cit-PAB-OH | DBCO-PEG5-acid | DBCO-NH-PEG4-amine | Mal-PEG1-NHS ester | Mal-PEG1-Val-Cit-PABC-OH | mPEG6-amine | Fmoc-N-amido-PEG9-acid
Send Inquiry
Verification code
Inquiry Basket